Literature DB >> 27666490

NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML.

Ashok Kumar Jayavelu1, Jennifer N Moloney2, Frank-D Böhmer3, Thomas G Cotter4.   

Abstract

In different types of myeloid leukemia, increased formation of reactive oxygen species (ROS) has been noted and associated with aspects of cell transformation, including the promotion of leukemic cell proliferation and migration, as well as DNA damage and accumulation of mutations. Work reviewed in this article has revealed the involvement of NADPH oxidase (NOX)-derived ROS downstream of oncogenic protein-tyrosine kinases in both processes, and the related pathways have been partially identified. FMS-like tyrosine kinase 3 with internal tandem duplications (FLT3-ITD), an important oncoprotein in a subset of acute myeloid leukemias, causes activation of AKT and, subsequently, stabilization of p22phox, a regulatory subunit for NOX1-4. This process is linked to ROS formation and DNA damage. Moreover, FLT3-ITD signaling through STAT5 enhances expression of NOX4, ROS formation, and inactivation of the protein-tyrosine phosphatase DEP-1/PTPRJ, a negative regulator of FLT3 signaling, by reversible oxidation of its catalytic cysteine residue. Genetic inactivation of NOX4 restores DEP-1 activity and attenuates cell transformation by FLT3-ITD in vitro and in vivo. Future work is required to further explore these mechanisms and their causal involvement in leukemic cell transformation, which may result in the identification of novel candidate targets for therapy.
Copyright © 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27666490     DOI: 10.1016/j.exphem.2016.08.008

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  24 in total

1.  Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3.

Authors:  Andrew J Robinson; Goitseone L Hopkins; Namrata Rastogi; Marie Hodges; Michelle Doyle; Sara Davies; Paul S Hole; Nader Omidvar; Richard L Darley; Alex Tonks
Journal:  Cancer Res       Date:  2019-12-20       Impact factor: 12.701

Review 2.  Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.

Authors:  Alessia Parascandolo; Mikko O Laukkanen
Journal:  Antioxid Redox Signal       Date:  2018-11-22       Impact factor: 8.401

Review 3.  Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.

Authors:  Anna Orlova; Bettina Wingelhofer; Heidi A Neubauer; Barbara Maurer; Angelika Berger-Becvar; György Miklós Keserű; Patrick T Gunning; Peter Valent; Richard Moriggl
Journal:  Expert Opin Ther Targets       Date:  2017-11-24       Impact factor: 6.902

4.  Nuclear membrane-localised NOX4D generates pro-survival ROS in FLT3-ITD-expressing AML.

Authors:  Jennifer N Moloney; Ashok Kumar Jayavelu; Joanna Stanicka; Sarah L Roche; Rebecca L O'Brien; Sebastian Scholl; Frank-D Böhmer; Thomas G Cotter
Journal:  Oncotarget       Date:  2017-11-01

Review 5.  Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.

Authors:  Rodrigo Prieto-Bermejo; Marta Romo-González; Alejandro Pérez-Fernández; Carla Ijurko; Ángel Hernández-Hernández
Journal:  J Exp Clin Cancer Res       Date:  2018-06-26

Review 6.  The Cooperative Relationship between STAT5 and Reactive Oxygen Species in Leukemia: Mechanism and Therapeutic Potential.

Authors:  Tian Mi; Zhengqi Wang; Kevin D Bunting
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

7.  Modulation of FLT3 signal transduction through cytoplasmic cysteine residues indicates the potential for redox regulation.

Authors:  Annette Böhmer; Saskia Barz; Katjana Schwab; Ulrike Kolbe; Anke Gabel; Joanna Kirkpatrick; Oliver Ohlenschläger; Matthias Görlach; Frank-D Böhmer
Journal:  Redox Biol       Date:  2019-09-08       Impact factor: 11.799

Review 8.  Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy.

Authors:  Yongfeng Chen; Yong Liang; Xingjing Luo; Qiongying Hu
Journal:  Cell Death Dis       Date:  2020-04-27       Impact factor: 8.469

9.  Andrographolide Suppresses MV4-11 Cell Proliferation through the Inhibition of FLT3 Signaling, Fatty Acid Synthesis and Cellular Iron Uptake.

Authors:  Xiao Chen; Jianbin Zhang; Lixia Yuan; Yifei Lay; Yin Kwan Wong; Teck Kwang Lim; Chye Sun Ong; Qingsong Lin; Jigang Wang; Zichun Hua
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

Review 10.  Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence.

Authors:  Salihanur Darici; Hazem Alkhaldi; Gillian Horne; Heather G Jørgensen; Sandra Marmiroli; Xu Huang
Journal:  J Clin Med       Date:  2020-09-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.